Oxepa Nutrition for Critical Care

Oxepa is a specialized therapeutic nutrition formula developed by Abbott for critically ill patients with acute respiratory distress. Unlike standard tube feeding formulas, Oxepa is designed for people on mechanical ventilation and those managing acute lung injury, where inflammation and oxygen exchange become central to recovery. It's a product clinicians reach for in intensive care settings, not a general-purpose supplement.

What sets this formula apart is its nutrient profile. Oxepa combines anti-inflammatory ingredients—including omega-3 fatty acids from fish oil (EPA and DHA), gamma-linolenic acid from borage oil, and elevated antioxidant levels—with a lower-carbohydrate, higher-fat composition. That macronutrient balance is deliberate: metabolizing fat produces less carbon dioxide than metabolizing carbohydrates, which can ease the ventilatory burden on patients already struggling to breathe. The result is a calorically dense enteral feed built around the specific demands of pulmonary compromise.

Buyers here are typically hospital purchasers, respiratory and critical care units, or caregivers continuing a feeding regimen prescribed at discharge. The most common questions are practical: Is it ready to hang or does it need mixing? Oxepa is a ready-to-use liquid formula intended for tube feeding. Does it require a prescription or clinical oversight? Because it's a medical nutrition therapy dosed to a patient's caloric and fluid needs, it should be used under the direction of a physician or registered dietitian, who will determine feeding rate and volume.

Store unopened containers at room temperature and follow the manufacturer's hang-time and handling guidance to maintain safety once a feeding is started. For related enteral options, feeding supplies, and other therapeutic formulas, browse our broader nutrition selection to compare products suited to different clinical conditions and delivery methods.